MWNA
ATEX icon

Marshall Wace North America’s Anterix ATEX Stock Holding History

Marshall Wace North America’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,030
Closed -$243K – 1422
2021
Q2 		$243K Sell
4,030
-5,605
-58% -$281K ﹤0.01% 1316
2021
Q1 		$454K Buy
+9,635
New +$396K ﹤0.01% 1227
2020
Q3 		– Sell
-13,167
Closed -$598K – 1196
2020
Q2 		$598K Buy
+13,167
New +$673K ﹤0.01% 890
2020
Q1 		– Sell
-3,581
Closed -$155K – 1219
2019
Q4 		$155K Sell
3,581
-31,781
-90% -$1.3M ﹤0.01% 1014
2019
Q3 		$1.28M Buy
+35,362
New +$1.49M 0.01% 639

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCC
Bain Capital Credit Boston, Massachusetts $368M AUM 9.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

Marshall Wace North America's ATEX Position: Q3 2021 in Review

Marshall Wace North America sold out of Anterix (ATEX) in Q3 2021, closing a stake of 4,030 shares — an estimated $243K sold.

Marshall Wace North America first reported a position in ATEX in Q3 2019 and held it in 5 quarters. The position peaked at $1.28M in Q3 2019. 107 funds tracked by Wall St. Rank hold ATEX as of Q3 2021.

  • Marshall Wace North America reported no remaining Anterix position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 4,030 Anterix shares in Q3 2021, an estimated $243K.
  • Marshall Wace North America first reported a position in Anterix in Q3 2019 and held it in 5 quarters.
  • Marshall Wace North America's Anterix position peaked at $1.28M in Q3 2019.
  • 107 funds tracked by Wall St. Rank held Anterix as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.